A Descriptive Report of Bleeding Complications Secondary to Warfarin Therapy

Abstract

Purpose

This study identified factors that contributed to bleeding complications associated with warfarin therapy that were documented as adverse drug reactions (ADRs).

Methods

A retrospective chart review was performed using the Medical Records Department's “E” code list of anticoagulant-related ADRs. Descriptive statistics were used to identify common factors associated with bleeding complications related to warfarin use.

Results

Patients 60 years of age or older experienced 78% of all events; a majority (81%) of reports involved the presence of comorbid conditions such as congestive heart failure, carcinoma, or sepsis. A supratherapeutic INR was documented for 75% of patients with anticoagulant-related ADRS.

Conclusions

Age, comorbid conditions, and anticoagulation intensity were identified as possible factors contributing to documented ADRs associated with warfarin therapy.

Keywords

anticoagulation therapy adverse drug reactions warfarin

Get full access to this article

View all access options for this article.

References

Cruickshank

, Ragg

Warfarin toxicity in the emergency department: Recommendations for management. Emerg Med. 2001; 13(1): 91–7.

Landefeld

C.S.

, Goldman

Major bleeding in outpatients treated with warfarin: Incidence and prediction of factors known at the start of outpatient therapy. Am J Med. 1989; 87: 144–52.

Landefeld

C.S.

, Cook

E.F.

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 1987; 82: 703–13.

Beyth

R.J.

Hemorrhagic complications of oral anticoagulant therapy. Clin Geriatr Med. 2001; 17(1): 49–56.

Gurwitz

J.H.

, Goldberg

R.J.

Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med. 1988; 148(8): 1733–6.

Bridgen

M.L.

, Kay

, Le

Audit of frequency and clinical response to excessive oral anticoagulation in an outpatient population. Am J Hematol. 1998; 59(1): 22–7.

van der Meer

F.J.

, Rosendaal

F.R.

Bleeding complications in oral anticoagulant therapy. Arch Intern Med. 1993; 153: 1557–62.

Landefeld

C.G.

, McGuire

A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 1990; 89: 569–78.

Fihn

S.D.

, McDonell

Risk factors for complications of chronic anticoagulation: A multicenter study. Arch Intern Med. 1993; 118: 511–20.

10.

Patterson

W.P.

, Ringenberg

Q.S.

The pathophysiology of thrombosis in cancer. Semin Oncol. 1990; 17: 140–6.